It aims mainly to enhance digestion
Oral semaglutide works by acting as a GLP-1 receptor agonist, helping to regulate appetite and reduce food intake
It is known as a triple-agonist , meaning it targets GLP-1, GIP, and glucagon receptors simultaneously
However, when food moves slower through your stomach, it also moves slower through your colon, creating an environment where water is reabsorbed more completely and stools become harder and drier
In 1967, Perley and Kipnis conducted a further study in which they showed that the insulin produced during the incretin effect in humans accounted for more than half of the total insulin secreted by oral glucose ingestion (Perley and Kipnis, 1967)
For Canadians using Retatrutide who suspect sleep apnea, discussing symptoms with your family physician is the first step